Product Name

  • Name

    3-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one

  • EINECS
  • CAS No. 79098-75-2
  • Article Data7
  • CAS DataBase
  • Density 1.18 g/cm3
  • Solubility
  • Melting Point
  • Formula C13H17N3O
  • Boiling Point 459.008 °C at 760 mmHg
  • Molecular Weight 231.297
  • Flash Point 231.4 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 79098-75-2 (3-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one)
  • Hazard Symbols
  • Synonyms 3-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one;3-Piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one;
  • PSA 44.37000
  • LogP 2.19080

Synthetic route

1-benzyl-4-(1,2,3,4-tetrahydro-2-oxo-3-quinazolinyl)piperidine
79098-88-7

1-benzyl-4-(1,2,3,4-tetrahydro-2-oxo-3-quinazolinyl)piperidine

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol for 48h;100%
With hydrogen; Pd/C In ethanol at 60℃; under 1500.15 Torr;85%
With hydrogen; palladium on activated charcoal In ethanol at 60℃; under 1500.15 Torr;85%
tert-butyl 4-(2-oxo-1,2,3,4-tetrahydroquinazolin-3-yl)piperidine-1-carboxylate
960221-97-0

tert-butyl 4-(2-oxo-1,2,3,4-tetrahydroquinazolin-3-yl)piperidine-1-carboxylate

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 20℃;92%
2-nitro-benzaldehyde
552-89-6

2-nitro-benzaldehyde

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium tetrahydroborate; methanol
2: hydrogen / palladium on activated charcoal / ethanol
3: acetonitrile / Reflux
View Scheme
4-amino-1-benzylpiperidine
50541-93-0

4-amino-1-benzylpiperidine

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium tetrahydroborate; methanol
2: hydrogen / palladium on activated charcoal / ethanol
3: acetonitrile / Reflux
View Scheme
Multi-step reaction with 5 steps
1: 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol; triethylamine / N,N-dimethyl-formamide / 5 h / 70 °C
2: trifluoroacetic acid / dichloromethane / 20 h / 0 - 20 °C
3: lithium aluminium tetrahydride / 1,4-dioxane / 3 h / Reflux
4: tetrahydrofuran / 5 h / 20 °C
5: hydrogen; palladium 10% on activated carbon / methanol / 48 h
View Scheme
2-amino-N-[1-(phenylmethyl)-4-piperidinyl]-benzenemethanamine
79099-03-9

2-amino-N-[1-(phenylmethyl)-4-piperidinyl]-benzenemethanamine

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Stage #1: 2-amino-N-[1-(phenylmethyl)-4-piperidinyl]-benzenemethanamine; 1,1'-carbonyldiimidazole In acetonitrile Reflux;
Stage #2: With hydrogen; palladium(II) hydroxide In methanol
(1-benzyl-piperidin-4-yl)-(2-nitro-benzyl)-amine
98754-28-0

(1-benzyl-piperidin-4-yl)-(2-nitro-benzyl)-amine

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogen / palladium on activated charcoal / ethanol
2: acetonitrile / Reflux
View Scheme
[2-(1-benzyl-piperidin-4-ylcarbamoyl)phenyl] tert-butyl carbamate

[2-(1-benzyl-piperidin-4-ylcarbamoyl)phenyl] tert-butyl carbamate

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: trifluoroacetic acid / dichloromethane / 20 h / 0 - 20 °C
2: lithium aluminium tetrahydride / 1,4-dioxane / 3 h / Reflux
3: tetrahydrofuran / 5 h / 20 °C
4: hydrogen; palladium 10% on activated carbon / methanol / 48 h
View Scheme
2-amino-N-(1-benzyl-piperidin-4-yl)-benzamide
83425-16-5

2-amino-N-(1-benzyl-piperidin-4-yl)-benzamide

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: lithium aluminium tetrahydride / 1,4-dioxane / 3 h / Reflux
2: tetrahydrofuran / 5 h / 20 °C
3: hydrogen; palladium 10% on activated carbon / methanol / 48 h
View Scheme
2-amino-N-[1-(phenylmethyl)-4-piperidinyl]-benzenemethanamine
79099-03-9

2-amino-N-[1-(phenylmethyl)-4-piperidinyl]-benzenemethanamine

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: tetrahydrofuran / 5 h / 20 °C
2: hydrogen; palladium 10% on activated carbon / methanol / 48 h
View Scheme
2-(tert-butyloxycarbonylamino)benzoic acid
68790-38-5

2-(tert-butyloxycarbonylamino)benzoic acid

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol; triethylamine / N,N-dimethyl-formamide / 5 h / 70 °C
2: trifluoroacetic acid / dichloromethane / 20 h / 0 - 20 °C
3: lithium aluminium tetrahydride / 1,4-dioxane / 3 h / Reflux
4: tetrahydrofuran / 5 h / 20 °C
5: hydrogen; palladium 10% on activated carbon / methanol / 48 h
View Scheme
tert-butyl 4-((2-aminobenzyl)amino)piperidine-1-carboxylate
79098-98-9

tert-butyl 4-((2-aminobenzyl)amino)piperidine-1-carboxylate

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / acetonitrile / 18 h / 20 °C / Reflux
2: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium tris(acetoxy)borohydride / dichloromethane / 48 h / 20 °C
2: triethylamine / acetonitrile / 18 h / 20 °C / Reflux
3: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
2-amino-1-benzylamine
4403-69-4

2-amino-1-benzylamine

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium tris(acetoxy)borohydride / dichloromethane / 48 h / 20 °C
2: triethylamine / acetonitrile / 18 h / 20 °C / Reflux
3: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
1,1'-Carbonyl-di-(1,2,4-triazole)
41864-22-6

1,1'-Carbonyl-di-(1,2,4-triazole)

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

2-Amino-3-(3,5-dibromo-4-hydroxy-phenyl)-propionic acid methyl ester; hydrochloride
61039-29-0

2-Amino-3-(3,5-dibromo-4-hydroxy-phenyl)-propionic acid methyl ester; hydrochloride

C24H26Br2N4O5

C24H26Br2N4O5

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran100%
1,1'-Carbonyl-di-(1,2,4-triazole)
41864-22-6

1,1'-Carbonyl-di-(1,2,4-triazole)

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

methyl 2-amino-3-(3-methoxyphenyl)propanoate hydrochloride

methyl 2-amino-3-(3-methoxyphenyl)propanoate hydrochloride

C25H30N4O5

C25H30N4O5

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran100%
1,1'-Carbonyl-di-(1,2,4-triazole)
41864-22-6

1,1'-Carbonyl-di-(1,2,4-triazole)

C8H12N2O2S*ClH

C8H12N2O2S*ClH

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C22H27N5O4S

C22H27N5O4S

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran100%
1,1'-Carbonyl-di-(1,2,4-triazole)
41864-22-6

1,1'-Carbonyl-di-(1,2,4-triazole)

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

3-Nitro-phenylalanin-methylester-hydrochlorid

3-Nitro-phenylalanin-methylester-hydrochlorid

C24H27N5O6

C24H27N5O6

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran100%
C13H13F3O4

C13H13F3O4

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C26H28F3N3O4

C26H28F3N3O4

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran100%
3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

(+/-)-4-(3,4-dimethoxyphenyl)-3-methoxycarbonylbutanoic acid
78647-52-6

(+/-)-4-(3,4-dimethoxyphenyl)-3-methoxycarbonylbutanoic acid

C27H33N3O6

C27H33N3O6

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran100%
β-(methoxycarbonyl)-1-naphthalenebutanoic acid
122872-06-4

β-(methoxycarbonyl)-1-naphthalenebutanoic acid

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C29H31N3O4

C29H31N3O4

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran100%
3,5-dimethyl-4-hydroxy-β-(methoxycarbonyl)-benzenebutanoic acid

3,5-dimethyl-4-hydroxy-β-(methoxycarbonyl)-benzenebutanoic acid

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C27H33N3O5

C27H33N3O5

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran100%
1-(methoxycarbonyl)-2-(2-((2-(trimethylsilyl)ethoxy)methyl)-7-methyl-2H-indazol-5-yl)ethyl 4-nitrophenyl carbonate
855778-81-3

1-(methoxycarbonyl)-2-(2-((2-(trimethylsilyl)ethoxy)methyl)-7-methyl-2H-indazol-5-yl)ethyl 4-nitrophenyl carbonate

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

1-(Methoxycarbonyl)-2-(2-((2-(trimethylsilyl)ethoxy)methyl)-7-methyl-2H-indazol-5-yl)ethyl 4-(1,2-dihydro-2-oxoquinazolin-3(4H)-yl)piperidine-1-carboxylate
865626-65-9

1-(Methoxycarbonyl)-2-(2-((2-(trimethylsilyl)ethoxy)methyl)-7-methyl-2H-indazol-5-yl)ethyl 4-(1,2-dihydro-2-oxoquinazolin-3(4H)-yl)piperidine-1-carboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In DMF (N,N-dimethyl-formamide) at 20℃; for 48h;100%
With N-ethyl-N,N-diisopropylamine In DMF (N,N-dimethyl-formamide) at 20℃; for 48h;100%
(R)-methyl 2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate
890044-58-3

(R)-methyl 2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

(R)-methyl-2-(4-(2-oxo-1,2-dihydroquinazolin-3(4H)-yl)piperidine-1-carboxamido)-3-(7-methyl-1H-indazol-5-yl)propanoate
890044-59-4

(R)-methyl-2-(4-(2-oxo-1,2-dihydroquinazolin-3(4H)-yl)piperidine-1-carboxamido)-3-(7-methyl-1H-indazol-5-yl)propanoate

Conditions
ConditionsYield
Stage #1: methyl (R)-2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate With di(succinimido) carbonate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In N,N-dimethyl-formamide for 24h;
100%
3,5-dibromo-4-hydroxy-β-(methoxycarbonyl)-benzenebutanoic acid
204695-24-9

3,5-dibromo-4-hydroxy-β-(methoxycarbonyl)-benzenebutanoic acid

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C25H27Br2N3O5

C25H27Br2N3O5

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine In tetrahydrofuran; N,N-dimethyl-formamide98%
3,5-dibromo-4-hydroxy-β-(methoxycarbonyl)-benzenebutanoic acid
204695-24-9

3,5-dibromo-4-hydroxy-β-(methoxycarbonyl)-benzenebutanoic acid

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C25H27Br2N3O5

C25H27Br2N3O5

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran98%
3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

(S)-2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-4-oxo-4-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-butyric acid methyl ester
688020-82-8

(S)-2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-4-oxo-4-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-butyric acid methyl ester

Conditions
ConditionsYield
Stage #1: (S)-2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-succinic acid 1-methyl ester With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In DMF (N,N-dimethylformamide) at 20℃; for 1h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In DMF (N,N-dimethylformamide) at 20℃;
Stage #3: With potassium carbonate; citric acid more than 3 stages;
98%
3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

3-(4-bromo-3-methyl-phenyl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-carbonyl]-amino}-propionic acid ethyl ester
688021-09-2

3-(4-bromo-3-methyl-phenyl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-carbonyl]-amino}-propionic acid ethyl ester

Conditions
ConditionsYield
Stage #1: 2-amino-3-(4-bromo-3-methyl-phenyl)-propionic acid ethyl ester hydrochloride With 1,1'-Carbonyl-di-(1,2,4-triazole); triethylamine In DMF (N,N-dimethylformamide) at 0 - 20℃; for 2h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In DMF (N,N-dimethylformamide) at 80℃; for 1.5h;
97%
1,1'-Carbonyl-di-(1,2,4-triazole)
41864-22-6

1,1'-Carbonyl-di-(1,2,4-triazole)

2-amino-3-(3,4-diethyl-phenyl)-propionic acid methylester
600725-39-1

2-amino-3-(3,4-diethyl-phenyl)-propionic acid methylester

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

3-(3,4-diethyl-phenyl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-carbonyl]-amino}-propionic acid methylester
686297-92-7

3-(3,4-diethyl-phenyl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-carbonyl]-amino}-propionic acid methylester

Conditions
ConditionsYield
Stage #1: 1,1'-Carbonyl-di-(1,2,4-triazole); 2-amino-3-(3,4-diethyl-phenyl)-propionic acid methylester With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 10℃; for 1.5h;
Stage #2: In DMF (N,N-dimethyl-formamide) for 0.5h;
Stage #3: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one for 10h; Heating / reflux;
97%
(5-bromouracil)acetic acid
31385-63-4

(5-bromouracil)acetic acid

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

5-bromo-1-{2-oxo-2-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione

5-bromo-1-{2-oxo-2-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
Stage #1: (5-bromouracil)acetic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In N,N-dimethyl-formamide at 20℃; for 18h;
97%
(+/-)-2-Amino-3-(7-chloro-1H-indazol-5-yl)-propionic acid methyl ester
635712-47-9

(+/-)-2-Amino-3-(7-chloro-1H-indazol-5-yl)-propionic acid methyl ester

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

(+/-)-3-(7-chloro-1H-indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid methyl ester
635710-82-6

(+/-)-3-(7-chloro-1H-indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid methyl ester

Conditions
ConditionsYield
Stage #1: (+/-)-2-Amino-3-(7-chloro-1H-indazol-5-yl)-propionic acid methyl ester; 1,1'-carbonyldiimidazole In tetrahydrofuran at 0 - 20℃; for 0.25h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In tetrahydrofuran at 20℃;
94%
In tetrahydrofuran
C17H20Br2O7

C17H20Br2O7

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C30H35Br2N3O7

C30H35Br2N3O7

Conditions
ConditionsYield
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine In tetrahydrofuran; N,N-dimethyl-formamide93%
C16H16O4

C16H16O4

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C29H31N3O4

C29H31N3O4

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran92%
(+/-)-2-Amino-3-(7-ethyl-1H-indazol-5-yl)-propionic acid methyl ester
635712-52-6

(+/-)-2-Amino-3-(7-ethyl-1H-indazol-5-yl)-propionic acid methyl ester

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

(+/-)-3-(7-ethyl-1H-indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid methyl ester
635710-84-8

(+/-)-3-(7-ethyl-1H-indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid methyl ester

Conditions
ConditionsYield
Stage #1: (+/-)-2-Amino-3-(7-ethyl-1H-indazol-5-yl)-propionic acid methyl ester; 1,1'-carbonyldiimidazole In tetrahydrofuran at 0 - 20℃; for 0.333333h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In tetrahydrofuran at 20℃;
92%
In tetrahydrofuran
1,1'-Carbonyl-di-(1,2,4-triazole)
41864-22-6

1,1'-Carbonyl-di-(1,2,4-triazole)

C10H11Br2NO2*ClH

C10H11Br2NO2*ClH

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C24H26Br2N4O4

C24H26Br2N4O4

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran90%
(R)-2-amino-3-[1-(2-trimethylsilanyl-ethanesulfonyl)-1H-indazol-5-yl]-propionic acid methyl ester
635713-85-8

(R)-2-amino-3-[1-(2-trimethylsilanyl-ethanesulfonyl)-1H-indazol-5-yl]-propionic acid methyl ester

di(succinimido) carbonate
74124-79-1

di(succinimido) carbonate

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

(R)-2-{[4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-3-[1-(2-trimethylsilanyl-ethanesulfonyl)-1H-indazol-5-yl]-propionic acid methyl ester
635713-93-8

(R)-2-{[4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-3-[1-(2-trimethylsilanyl-ethanesulfonyl)-1H-indazol-5-yl]-propionic acid methyl ester

Conditions
ConditionsYield
Stage #1: (R)-2-amino-3-[1-(2-trimethylsilanyl-ethanesulfonyl)-1H-indazol-5-yl]-propionic acid methyl ester; di(succinimido) carbonate With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 0.666667h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In dichloromethane at 20℃;
90%
With N-ethyl-N,N-diisopropylamine In dichloromethane1.15 g (90%)
3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

2-(4-chloro-3-trifluoromethyl-benzyl)-4-oxo-4-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-butanoic acid methyl ester
688021-42-3

2-(4-chloro-3-trifluoromethyl-benzyl)-4-oxo-4-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-butanoic acid methyl ester

Conditions
ConditionsYield
Stage #1: 2-(4-chloro-3-trifluoromethyl-benzyl)-succinic acid 1-methyl ester With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran; water at 20℃; for 0.166667h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In tetrahydrofuran; water at 20℃; for 2h;
Stage #3: With sodium hydrogencarbonate In water
89%
3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

3,5-dibromo-D-tyrosine methyl ester

3,5-dibromo-D-tyrosine methyl ester

(R)-N-(1-oxo-(3,4-dihydroquinazolin-2(1H)-yl)piperidinyl)-3,5-dibromotyrosine methylester

(R)-N-(1-oxo-(3,4-dihydroquinazolin-2(1H)-yl)piperidinyl)-3,5-dibromotyrosine methylester

Conditions
ConditionsYield
Stage #1: 1,1'-carbonyldiimidazole; 3,5-dibromo-D-tyrosine methyl ester With 1,2,4-Triazole In DMF (N,N-dimethyl-formamide) at 10 - 20℃; for 2h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In DMF (N,N-dimethyl-formamide) at 50 - 55℃; for 1.5h;
88%
Stage #1: 1,1'-carbonyldiimidazole; 3,5-dibromo-D-tyrosine methyl ester With 1,2,4-Triazole In DMF (N,N-dimethyl-formamide) at 10 - 20℃; for 2h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In DMF (N,N-dimethyl-formamide) at 20 - 55℃; for 1.5h; Product distribution / selectivity;
88%
With 1,2,4-Triazole In N,N-dimethyl-formamide51%
C15H22N2O2
936572-64-4

C15H22N2O2

di(succinimido) carbonate
74124-79-1

di(succinimido) carbonate

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

C29H37N5O4

C29H37N5O4

Conditions
ConditionsYield
In dichloromethane87%
4-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-3,3-bis-ethoxycarbonyl-butanoic acid
600725-56-2

4-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-3,3-bis-ethoxycarbonyl-butanoic acid

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-{2-oxo-2-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-ethyl}-malonic acid diethyl ester
688020-58-8

2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-{2-oxo-2-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-ethyl}-malonic acid diethyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine In tetrahydrofuran at 20℃; for 16h;87%
3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

6,7-dimethoxy-4-chloroquinazoline
13790-39-1

6,7-dimethoxy-4-chloroquinazoline

3-[1-(6,7-Dimethoxy-quinazolin-4-yl)-piperidin-4-yl]-3,4-dihydro-1H-quinazolin-2-one; hydrochloride
99161-60-1

3-[1-(6,7-Dimethoxy-quinazolin-4-yl)-piperidin-4-yl]-3,4-dihydro-1H-quinazolin-2-one; hydrochloride

Conditions
ConditionsYield
In methanol Heating;86%
(+/-)-2-amino-3-(7-ethyl-3 methyl-1H-indazol-5-yl)-propionic acid methyl ester
773887-24-4

(+/-)-2-amino-3-(7-ethyl-3 methyl-1H-indazol-5-yl)-propionic acid methyl ester

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one
79098-75-2

3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one

(+/-)-3-(7-ethyl-3-methyl-1H-indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid methyl ester
855776-60-2

(+/-)-3-(7-ethyl-3-methyl-1H-indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid methyl ester

Conditions
ConditionsYield
Stage #1: (+/-)-2-amino-3-(7-ethyl-3 methyl-1H-indazol-5-yl)-propionic acid methyl ester; 1,1'-carbonyldiimidazole In tetrahydrofuran at 0 - 20℃; for 0.25h;
Stage #2: 3-piperidin-4-yl-3,4-dihydro-1H-quinazoline-2-one In tetrahydrofuran at 20℃;
86%

3-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one Specification

The 3-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one, its cas register number is 79098-75-2. It also can be called as 2(1H)-Quinazolinone,3,4-dihydro-3-(4-piperidinyl)- and the Systematic name about this chemical is 3-piperidin-4-yl-3,4-dihydroquinazolin-2(1H)-one.

Following are the chemical properties about 3-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one: (1)#H bond acceptors: 4; (2)#H bond donors: 2; (3)#Freely Rotating Bonds: 1; (4)Polar Surface Area: 44.37Å2; (5)Index of Refraction: 1.581; (6)Molar Refractivity: 65.311 cm3; (7)Molar Volume: 195.993 cm3; (8)Polarizability: 25.891x10-24cm3; (9)Surface Tension: 45.599 dyne/cm; (10) Enthalpy of Vaporization: 71.942 kJ/mol; (11)Boiling Point: 459.008 °C at 760 mmHg

This chemical can be described computed from structure:
(1)SMILES:O=C2N(Cc1ccccc1N2)C3CCNCC3
(2)InChI: InChI=1/C13H17N3O/c17-13-15-12-4-2-1-3-10(12)9-16(13)11-5-7-14-8-6-11/h1-4,11,14H,5-9H2,(H,15,17)
(3)InChIKey: KSTFHYBYFDYWSD-UHFFFAOYAK
(4)Std. InChI: InChI=1S/C13H17N3O/c17-13-15-12-4-2-1-3-10(12)9-16(13)11-5-7-14-8-6-11/h1-4,11,14H,5-9H2,(H,15,17)
(5)Std. InChIKey: KSTFHYBYFDYWSD-UHFFFAOYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View